Rockefeller Capital Management
DTIL icon

Rockefeller Capital Management’s Precision BioSciences DTIL Stock Holding History

Rockefeller Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.5K Hold
1,000
– – ﹤0.01% 4211
2025
Q4 		$4.16K Hold
1,000
– – ﹤0.01% 4132
2025
Q3 		$5.52K Buy
+1,000
New +$4.79K ﹤0.01% 3843
2020
Q4 		– Sell
-767
Closed -$141K – 2883
2020
Q3 		$141K Buy
767
+312
+69% +$62.1K ﹤0.01% 1153
2020
Q2 		$114K Buy
+455
New +$99.6K ﹤0.01% 1123

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rockefeller Capital Management's DTIL Position: Q1 2026 in Review

Rockefeller Capital Management held its Precision BioSciences (DTIL) position steady in Q1 2026 at 1,000 shares worth $5.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4211.

Rockefeller Capital Management first reported a position in DTIL in Q2 2020 and has held it in 5 quarters since. The position peaked at $141K in Q3 2020. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Rockefeller Capital Management held 1,000 shares of Precision BioSciences worth $5.5K as of Q1 2026.
  • Rockefeller Capital Management left its Precision BioSciences share count unchanged in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4211 holding.
  • Rockefeller Capital Management first reported a position in Precision BioSciences in Q2 2020 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Precision BioSciences position peaked at $141K in Q3 2020.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.